Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency AskBio Inc. (AskBio), a ...
Future treatment approaches for Parkinson’s disease, including gene therapy, stem cell applications and next-generation ...
Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...
Add Yahoo as a preferred source to see more of our stories on Google. The Hope Biosciences Research Foundation has uncovered the disease-modifying potential of a stem cell therapy in Parkinson's ...
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...
Researchers at Baylor College of Medicine have developed a combined computational and experimental strategy to distinguish genetic changes that promote Parkinson’s disease from those that protect ...
Recon: AbbVie Adds Parkinson’s Gene Therapy to Voyager Pact; Sanofi Says it Gave Payers $12B in Rebates in 2018 Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence ...
Reimbursement systems in Belgium and Europe are not prepared for cell and gene therapies Bayer’s Benelux head, Niels Hessmann ...
Bayer AG’s BAYRY wholly owned, independently operated subsidiary BlueRock Therapeutics LP announced positive 36-month data from an early-stage study of bemdaneprocel, an investigational cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results